Aurora Cannabis Shares Catch Fire on Positive Q3/20 Financial Results
Source: Streetwise Reports  (5/15/20)
Shares of Aurora Cannabis traded 60% higher after the company reported an 18% rise in net revenue, which included a 24% increase in consumer sales versus to the prior quarter. More >

Biotech Expands Antibody Research Across Multiple Neurodegenerative Diseases and Covid-19
Source: Streetwise Reports  (5/14/20)
ProMIS Neurosciences advances its various antibody programs related to neurodegenerative diseases and viral infections such as Covid-19. More >

Allogene Therapeutics Shares Climb 30% on Phase 1 Relapsed/Refractory NHL Study Data
Source: Streetwise Reports  (5/14/20)
Shares of Allogene Therapeutics traded higher and reached a new 52-week high price after the company reported initial results from its Phase 1 relapsed/refractory non-Hodgkin lymphoma trial. More >

Acceleration of COVID-19 Vaccine Programs Could Benefit U.S. Biotech
Source: Streetwise Reports  (5/13/20)
The development timeline for Inovio Pharmaceuticals' coronavirus vaccine candidate is discussed in an H.C. Wainwright & Co. report. More >

Biotech Advances Accurate SARS CoV-2 Antibodies Detection Test
Source: Streetwise Reports  (5/13/20)
Testing and validation of ProMIS Neurosciences' antibody targets will be conducted over the coming weeks. More >

MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results
Source: Streetwise Reports  (5/11/20)
Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy. More >

Pharmaceutical Firm Gains Ethics Approval for Phase 2 Human IPF and Chronic Cough Trial
Source: Streetwise Reports  (5/10/20)
Algernon Pharmaceuticals reported that it has received ethics approval in Australia for a Phase 2 human clinical study of NP-120 (Ifenprodil) for use in treatment of idiopathic pulmonary fibrosis and chronic cough. More >

Protagonist's Shares Nearly Double After Reporting Q1 Earnings and Positive Phase 2 Trial Results
Source: Streetwise Reports  (5/8/20)
Shares of Protagonist Therapeutics traded higher and reached a new 52-week high price after the company released Q1/20 financial results and positive data from its Phase 2 study of PTG-300 in patients with polycythemia vera, a type of blood cancer. More >

Canadian Firm Partners for US Sales of Its Telehealth Platform
Source: Streetwise Reports  (5/7/20)
This arrangement will bolster the use of CloudMD Software & Services' software in the United States. More >

Building a Better Covid-19 Antibody Test
Source: Streetwise Reports  (5/6/20)
ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. More >

California Biotech Partners for Manufacture of COVID-19 Vaccine Candidate
Source: Streetwise Reports  (5/6/20)
Arcturus Therapeutics Holdings' arrangement is explained and commented on in an H.C. Wainwright & Co. report. More >

Biotech Develops Antagonists for Protein Tied to Neurodegenerative Diseases
Source: Streetwise Reports  (5/6/20)
ProMIS Neurosciences' antagonists prevent dysfunctional protein aggregation. More >

Horizon Therapeutics Shares Rise 15% on Strong Q1 Results and Raised F/Y Sales Guidance
Source: Streetwise Reports  (5/6/20)
Shares of Horizon Therapeutics traded higher setting a new 52-week high price after the company reported a 27% y-o-y increase in net sales for Q1/20 and raised FY/20 net sales guidance. More >

Firm Partners with Canada's Largest Western Grocery Chain and Leading Community Pharmacy to Pilot In-Store Virtual Patient Care
Source: Streetwise Reports  (5/5/20)
CloudMD announced that it is partnering with Save-On-Foods grocery stores and Pure Integrative Pharmacy to pilot on demand, integrated virtual patient care through telemedicine kiosks placed in pharmacies' existing consult rooms. More >

Alexion's Buyout of Portola Pharmaceuticals Gets Investors' Blood Flowing
Source: Streetwise Reports  (5/5/20)
Shares of Portola Pharmaceuticals traded 130% higher after the company reported that it has received an $18 per share buyout offer from Alexion Pharmaceuticals. More >

Telehealth Platform Added to Vendor Lists of Leading Medical Associations
Source: Streetwise Reports  (5/4/20)
Use of CloudMD Software & Services' health solution is seeing significant growth. More >

Firm Creates Novel Intrabodies for ALS and Other Neurodegenerative Diseases
Source: Streetwise Reports  (5/4/20)
ProMIS Neurosciences reported it has generated novel intrabodies that are highly selective for misfolded forms of TAR DNA-binding protein 43 implicated in several neurologic disorders. More >

Stemline Shares Take Off on $677 Million Buyout Offer by Global Pharmaceutical Firm
Source: Streetwise Reports  (5/4/20)
Shares of Stemline Therapeutics traded 150% higher after the company reported that it has entered into a definitive agreement to be acquired by Italy's Menarini Group in a deal valued at up to $677 million. More >

Seattle Genetics Shares Trade Higher on Q1/20 Earnings and 22% Growth in ADCETRIS Sales
Source: Streetwise Reports  (5/1/20)
Seattle Genetics shares traded 8% higher, reaching a new 52-week high, after the company reported Q1/20 financial results which included a 10% y-o-y increase in net revenues fueled by a 22% increase in sales of ADCETRIS® and a strong debut for PADCEVâ„¢ in its first full quarter of sales. More >

Biotech Cleared for Phase 2b/3 Trial of NMDA Receptor Antagonist for COVID-19 Patients in Canada
Source: Streetwise Reports  (4/30/20)
Algernon Pharmaceuticals reported it received approval from Health Canada for a Phase 2b/3 multinational clinical study of Ifenprodil in COVID-19 patients to prevent progression to intubation and mechanical ventilation. More >

Mobile Health Solutions Firm Welcomes 8 New Texas Clients to Its Telemedicine Platform
Source: Streetwise Reports  (4/30/20)
Reliq Health Technologies reported that it has signed contracts to add eight new customers in Texas including an oncology practice that will be using its new iUGO Care Principal Care Management module. More >

US Counties to Use Tech Firm's Software for COVID-19 Contact Tracing
Source: Streetwise Reports  (4/29/20)
Demand has been taking off for HealthSpace Data Systems' platform released two weeks ago. More >

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients
Source: Streetwise Reports  (4/29/20)
Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. More >

With Contact Tracing Key to Reopening the Economy, New Cloud Platform Attracting High-Profile Users
Source: Streetwise Reports  (4/28/20)
As contact tracing moves to center stage as a key to reopening the economy, HealthSpace releases a scalable cloud-based system that is rapidly being adopted, including by the state of Hawaii. More >

Why These 2 Investment Professionals Say This Telemedicine Company Is One of Their Top Picks
Source: Streetwise Reports  (4/28/20)
As the coronavirus pandemic has accelerated the move to telemedicine, two investment professionals are following CloudMD, a small cap rapidly expanding in Canada. More >